Skip to main content

Table 2 Properties of engineered CRRISPR-Cas9 variants

From: CRISPR-Cas gene editing technology and its application prospect in medicinal plants

Engineered Cas9 variants

Included mutations

PAM (5′ to 3′)

Notes

Refs.

SpCas9 VRER

D1135V, G1218R, R1335E, T1337R of SpCas9 mutations

NGCG

Altered PAM variant; Bacterial-selection-based screening

[41, 60]

SpCas9 VQR

D1135V, R1335Q, T1337R of SpCas9 mutations

NGAN or NGNG

Altered PAM variant; Bacterial-selection-based screening

[41, 60]

SpCas9 EQR

D1135E, R1335Q, T1337R of SpCas9 mutations

NGAG

Altered PAM variant; Bacterial-selection-based screening

[61]

SpCas9-NG

R1335V, L1111R, D1135V, G1218R, E1219F, A1322R, T1337R of SpCas9 mutations

NG

Altered PAM variant

[62]

SpG

D1135L, S1136W, G1218K, E1219Q, R1335Q, T1337R of SpCas9 mutations

NGN

A near-PAMless variant

[43, 63]

SpRY

A61R, L1111R, N1317R, A1322R, R1333P introduced into SpG

NRN, NYN

A near-PAMless variant

[43, 63]

xCas9 3.7

E480K, E543D, E1219V, A262T, R324L, S409I, M694I of SpCas9 mutations

NG, GAA, GAT

Expanded PAM recognition range; Phage-assisted continuous evolution (PACE)

[25, 59]

SpCas9-HF1

N497A, R661A, Q695A, Q926A of SpCas9 mutations

NGG

Enhanced specificity

[64]

eSpCas9 (1.0)

K810A, K1003A, R1060A of SpCas9 mutations

NGG

Enhanced specificity; Structure-guided protein engineering

[65]

eSpCas9 (1.1)

K848A, K1003A, R1060A of SpCas9 mutations

NGG

Enhanced specificity; Structure-guided protein engineering

[65, 66]

evoCas9

M495V, Y515N, K526E, R661Q of SpCas9 mutations

NGG

Enhanced specificity; Yeast-based screening

[42]

HypaCas9

N692A, M694A, Q695A, H698A of SpCas9 mutations

NGG

Enhanced specificity

[67]

HiFi Cas9

single point mutation R691A of SpCas9

NGG

Enhanced specificity for ribonucleoprotein delivery

[68]

KKH SaCas9

E782K, N968K, R1015H of SaCas9 mutations

NNNRRT

Altered PAM variant

[69, 70]

SaCas-HF

R245A, N413A, N419A, R654A of SaCas9 mutations

NNGRRT

Enhanced specificity and genome-wide targeting accuracy

[69, 70]

efSaCas9

single point mutation N260D of SaCas9 variant Mut268

NNGRRT

Enhanced specificity; Human cells-based screening

[71, 72]

(HiFi-)Sc++

Thr1227Lys, Arg701Ala mutations and loop sequence from S. anginosus introduced into ScCas9

NNG

Enhanced specificity and activity

[73, 74]